Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:LVGO Livongo Health (LVGO) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Livongo Health Stock (NASDAQ:LVGO) 30 days 90 days 365 days Advanced Chart Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get Livongo Health alerts:Sign Up Key Stats Today's Range$139.77▼$139.7750-Day Range$136.67▼$148.0852-Week Range$18.76▼$151.05VolumeN/AAverage Volume3.04 million shsMarket Capitalization$14.20 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewLivongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California.Read More… Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Receive LVGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Livongo Health and its competitors with MarketBeat's FREE daily newsletter. Email Address LVGO Stock News HeadlinesDefine Ventures Appoints Bruce Broussard as Venture PartnerOctober 22, 2024 | uk.finance.yahoo.comMendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical ProceduresSeptember 26, 2024 | businesswire.comThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…November 23, 2024 | WealthPress (Ad)David P Fialkow's Net WorthMay 19, 2024 | benzinga.comDiabetes management startup Clivi wants to be ‘Livongo of Latin America’June 20, 2023 | news.yahoo.comSalvo Health Secures $10.5 Million in Seed Funding To Scale Virtual Health Clinic for Chronic ConditionsAugust 9, 2022 | tmcnet.comDown 87%, Could Teladoc Health Stock Actually Be A Buy?August 1, 2022 | investing.comHomeward partners with Rite Aid to deliver rural health careMay 31, 2022 | bizjournals.comSee More Headlines LVGO Stock Analysis - Frequently Asked Questions How were Livongo Health's earnings last quarter? Livongo Health, Inc. (NASDAQ:LVGO) issued its quarterly earnings results on Wednesday, October, 28th. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.11. The firm had revenue of $106.10 million for the quarter, compared to analysts' expectations of $95.57 million. Livongo Health had a positive trailing twelve-month return on equity of 0.29% and a negative net margin of 12.20%. When did Livongo Health IPO? Livongo Health (LVGO) raised $230 million in an initial public offering on Thursday, July 25th 2019. The company issued 10,700,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan acted as the underwriters for the IPO and Piper Jaffray, SVB Leerink, Canaccord Genuity, KeyBanc Capital Markets and Needham & Company were co-managers. What other stocks do shareholders of Livongo Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Livongo Health investors own include NVIDIA (NVDA), Teladoc Health (TDOC), Tesla (TSLA), Meta Platforms (META), Block (SQ), PayPal (PYPL) and Salesforce (CRM). Company Calendar Last Earnings10/28/2020Today11/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Computer Programming, Data Processing, & Other Computer Related Sub-IndustryN/A Current SymbolNASDAQ:LVGO CUSIPN/A CIKN/A Webwww.livongo.com Phone866-435-5643FaxN/AEmployees471Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-55,270,000.00 Net Margins-12.20% Pretax MarginN/A Return on Equity0.29% Return on Assets0.21% Debt Debt-to-Equity Ratio0.69 Current Ratio19.88 Quick Ratio19.51 Sales & Book Value Annual Sales$170.20 million Price / Sales83.42 Cash FlowN/A Price / Cash FlowN/A Book Value$5.37 per share Price / Book26.03Miscellaneous Outstanding Shares101,585,000Free FloatN/AMarket Cap$14.20 billion OptionableNot Optionable Beta1.81 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (NASDAQ:LVGO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Livongo Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Livongo Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.